CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Walton, M. I.; Eve, P. D.; Hayes, A.; Valenti, M. R.; De Haven Brandon, A. K.; Box, G.; Hallsworth, A.; Smith, E. L.; Boxall, K. J.; Lainchbury, M.; Matthews, T. P.; Jamin, Y.; Robinson, S. P.; Aherne, G. W.; Reader, J. C.; Chesler, L.; Raynaud, F. I.; Eccles, S. A.; Collins, I.; Garrett, M. D.

期刊名称Clinical Cancer Research
作者Walton, M. I.; Eve, P. D.; Hayes, A.; Valenti, M. R.; De Haven Brandon, A. K.; Box, G.; Hallsworth, A.; Smith, E. L.; Boxall, K. J.; Lainchbury, M.; Matthews, T. P.; Jamin, Y.; Robinson, S. P.; Aherne, G. W.; Reader, J. C.; Chesler, L.; Raynaud, F. I.; Eccles, S. A.; Collins, I.; Garrett, M. D.
卷第18卷
期第20期
印刷ISSN1078-0432
电子ISSN1557-3265
文件大小1113.73KB
发表时间2012-10-15
DOI10.1158/1078-0432.CCR-12-1322
页码5650-5661

发现好书期刊，享受阅读乐趣

CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs